Optiscan – Automated Bedside Glucose Monitoring for Critical Care

Posted March 20, 2019

OptiScan Biomedical Completes $20 Million Series E Financing

Proceeds to Support U.S. Commercialization of OptiScanner 5000 and Ongoing Platform Expansion Company’s First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units to be Highlighted [...]

By Optiscan

In Press Releases

Posted May 22, 2018

OptiScan Biomedical Announces Appointment of Cary G. Vance as President and Chief Executive Officer

Hayward, CA, May 22, 2018 – OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU), today announced [...]